Quick answer GHK-Cu (Copper Peptide) is an educational research profile for people comparing mechanism, potential benefits, evidence strength, and related compounds in anti-aging & longevity
Some people experience constipation only during the early weeks of starting or increasing their GLP-1 dose
Interorgan ammonia metabolism in liver failure: the basis of current and future therapies
It showed that the relative risks for aspiration, aspiration pneumonia, pneumonia, or respiratory failure were not elevated in patients prescribed GLP-1 RA compared to those receiving dipeptidylpeptidase-4 (DPP-4) inhibitors [21]
Despite their diverse pharmacological properties, these substances converge on shared mechanisms of neurotoxicity, including oxidative stress, mitochondrial dysfunction, excitotoxicity, and neuroinflammation
Whether indefinite use of a GLP-1 agonist is safe and appropriate is still being debated